Health Care [ 4/12 ] | Life Sciences Tools & Services [ 46/75 ]
NYSE | Common Stock
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets.
The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems.
This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses.
The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services.
This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise.
In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software.
The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments.
It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce.
Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 24, 25 | 1.59 Increased by +8.90% | 1.58 Increased by +0.63% |
| Aug 27, 25 | 1.37 Increased by +3.79% | 1.37 |
| May 28, 25 | 1.31 Increased by +7.38% | 1.26 Increased by +3.97% |
| Feb 26, 25 | 1.31 Increased by +1.55% | 1.27 Increased by +3.15% |
| Nov 25, 24 | 1.46 Increased by +5.80% | 1.41 Increased by +3.55% |
| Aug 21, 24 | 1.32 Decreased by -7.69% | 1.26 Increased by +4.76% |
| May 29, 24 | 1.22 Decreased by -3.94% | 1.19 Increased by +2.52% |
| Feb 27, 24 | 1.29 Decreased by -5.84% | 1.22 Increased by +5.74% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Oct 31, 25 | 1.86 B Increased by +9.41% | 434.00 M Increased by +23.65% | Increased by +23.32% Increased by +13.02% |
| Jul 31, 25 | 1.74 B Increased by +10.14% | 336.00 M Increased by +19.15% | Increased by +19.33% Increased by +8.18% |
| Apr 30, 25 | 1.67 B Increased by +6.04% | 215.00 M Decreased by -30.19% | Increased by +12.89% Decreased by -34.17% |
| Jan 31, 25 | 1.68 B Increased by +1.39% | 318.00 M Decreased by -8.62% | Increased by +18.92% Decreased by -9.87% |
| Oct 31, 24 | 1.70 B Increased by +0.77% | 351.00 M Decreased by -26.11% | Increased by +20.63% Decreased by -26.67% |
| Jul 31, 24 | 1.58 B Decreased by -5.62% | 282.00 M Increased by +154.05% | Increased by +17.87% Increased by +169.19% |
| Apr 30, 24 | 1.57 B Decreased by -8.39% | 308.00 M Increased by +1.99% | Increased by +19.58% Increased by +11.32% |
| Jan 31, 24 | 1.66 B Decreased by -5.58% | 348.00 M Decreased by -1.14% | Increased by +20.99% Increased by +4.71% |